Skip to main content

Table 3 Adherence to the lifestyle intervention program within the first 3 months and baseline characteristics (n = 26)

From: Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)

  Adherence positive
(≥ 70% participation in the intervention sessions)
Adherence negative
(< 70% participation in the intervention sessions)
P-value
Nutrition courses 21/26 (81%) 5/26 (19%)  
 Cancer, n 16 2 0.610
 Age*, years 43 (29–72) 41 (28–49) 0.686
 BMI*, kg/m2 23 (18–45) 24 (20–37) 0.610
 VO2peak*, ml/kg/min 24 (12–42) 23 (16–41) 0.952
 O2 at VT1*, ml/kg/min 14 (8–28) 14 (10–21) 0.343
IPAQ, MET*min/wk 5130 (347–14,166) 6167 (4583–7812) 0.629
Training courses 21/26 (81%) 5/26 (19%)  
 Cancer, n 14 4 0.114
 Age*, years 42 (28–72) 41 (36–51) 0.286
 BMI*, kg/m2 23 (18–45) 24 (20–37) 0.857
 VO2peak*, ml/kg/min 24 (12–42) 22 (16–37) 0.467
 O2 at VT1*, ml/kg/min 14 (8–28) 15 (10–21) 1.000
 IPAQ, MET*min/wk 5376 (347–14,166) 5375 (2826–7812) 0.970
Nutrition and training 19/26 (73%) 7/26 (27%)  
 Cancer, n 14 4 0.534
 Age*, years 43 (29–27) 41 (28–51) 0.821
 BMI*, kg/m2 23 (18–45) 24 (20–37) 0.778
 VO2peak*, ml/kg/min 24 (12–42) 23 (16–41) 0.955
 O2 at VT1*, ml/kg/min 14 (8–28) 15 (10–21) 0.642
IPAQ, MET*min/wk 5376 (347–14,166) 5576 (2826–7812) 0.974
  1. *Median (Range)